Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study

Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study.

OBJECTIVE To assess the fetal loss rate following amniocentesis and chorionic villus sampling (CVS). METHODS This was a national registry-based cohort study, including all singleton pregnant women who had an amniocentesis (n = 32 852) or CVS (n = 31 355) in Denmark between 1996 and 2006. Personal registration numbers of women having had an amniocentesis or a CVS were retrieved from the Danish...

Amniocentesis and Chorionic Villus Sampling

Procedure-related complications after genetic amniocentesis and chorionic villus sampling.

PURPOSE Amniocentesis (AC) and chorionic villus sampling (CVS) play an important role in the diagnosis of genetic anomalies. The aim of this study was to evaluate presentable numbers of procedure-related complications of genetic interventions in a tertiary referral hospital. MATERIALS AND METHODS The pregnancy outcome of women who underwent genetic AC or CVS during 2003-2010 at the Department...

Comparison of Complications of Chorionic Villus Sampling and Amniocentesis

Amniocentesis and chorionic villus sampling for prenatal diagnosis.

BACKGROUND A major disadvantage of second trimester amniocentesis is that the result is usually available only after 18 weeks' gestation. Chorionic villus sampling (CVS) and early amniocentesis can be done between 9 and 14 weeks and offer an earlier alternative. OBJECTIVES The objective was to assess comparative safety and accuracy of second trimester amniocentesis, early amniocentesis, trans...